Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain

American Journal of Therapeutics

Volumn 13, Issue 4, 2006, Pages 300-305

  Webster, Lynn R ^a,b   Walker, Mary Jean ^a  

^a Lifetree Clinical Research and Pain Clinic   (United States)

^b NONE   (United States)

Author keywords

Complex regional pain syndrome; Continuous infusion; Ketamine; Neuropathic pain; NMDA receptor antagonists

Indexed keywords

ANALGESIC AGENT; KETAMINE;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CONFUSION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INFUSION; DRUG SAFETY; ERYTHEMA; FATIGUE; FEMALE; HALLUCINATION; HEALTH CARE PERSONNEL; HOT FLUSH; HUMAN; INJECTION SITE INFLAMMATION; INJECTION SITE IRRITATION; INJECTION SITE REACTION; LONG TERM CARE; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; NEUROPATHIC PAIN; OUTPATIENT; PAIN ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINAL PAIN; THIRST; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; ANESTHETICS, DISSOCIATIVE; COMPLEX REGIONAL PAIN SYNDROMES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; OUTPATIENTS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES;

EID: 33749362313     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200607000-00004     Document Type: Article

References (18)

1. Fine P. Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain. J Pain Symptom Manage. 1999;17:296-300.
2. Bell R, Eccleston C, Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2003:CD003351.
3. Felsby S, Nielsen J, Arendt-Nielsen L, et al. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain. 1996;64:283-291.
4. Cohen S, DeJesus M. Ketamine patient-controlled analgesia for dysesthetic central pain. Spinal Cord. 2004;42:425-428.
5. Eide PK, Jorum E, Stubhaug A, et al. Relief of postherpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 1994;58:347-354.
6. Eide PK, Stubhaug A, Oye I, et al. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 1995;61:221-228.
7. Sang C. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. J Pain Symptom Manage. 2000;19(Suppl 1):S21-S25.
8. Harbut RE, Correll GE. Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient. Pain Med. 2002;3:147-155.
9. Schwartzman RJ, Goldberg ME, Dotson J, et al. Multi-day low dose ketamine infusion for the treatment of complex regional pain syndrome (CRPS). A15. Neurology. 2004;62(suppl 5).
10. Webster LR, Walker MJ. Safety and effectiveness of prolonged outpatient ketamine infusions for neuropathic pain. Presented at the 6th International Conference on Mechanisms and Treatment of Neuropathic Pain, San Francisco, 2003.
11. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg. 2003;97:1730-1739.
12. Backonja M, Arndt G, Gombar KA, et al. Response of chronic neuropathic pain syndrome to ketamine: a preliminary study. Pain. 1994;56:51-57.
13. Bennett GJ. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage. 2000;19(Suppl 1):S2-S6.
14. Price DD, Mayer DJ, Jianren M, et al. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage. 2000;19(Suppl 1):S7-S11.
15. Walker SM, Cousins MJ. Reduction in hyperalgesia and intrathecal morphine requirements by low-dose ketamine infusion. J Pain Symptom Manage. 1997;14:129-132.
16. Broadley KE, Kurowska A, Tookman A. Ketamine injection used orally. Palliat Med. 1996;10:247-250.
17. Petrenko AB, Yamakura T, Baba H, et al. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108-1116.
18. Leung A, Wallace MS, Ridgeway B, et al. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 2001;91:177-187.